ING Knock-Out AEX/ DE000NG51PU4 /
30/05/2024 19:39:00 | Chg.+0.060 | Bid21:59:31 | Demandez à21:59:31 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
26.140EUR | +0.23% | - Bid taille: - |
- Ask la taille: - |
AEX-INDEX | 647.97 - | 31/12/2078 | Call |
GlobeNewswire
07:30
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
GlobeNewswire
07:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
07:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
07:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
07:00
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
07:00
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
06:08
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
05:00
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options
GlobeNewswire
04:38
Avaada Energy Secures 1050 MWp Solar Project in NTPC Auction; Crosses over 15 GWp Portfolio in India
GlobeNewswire
03:41
United States Government to Reinstate Section 301 Import Tariffs on Artificial Graphite from China
GlobeNewswire
03:16
Lowey Dannenberg, P.C. is Investigating Akero Therapeutics, Inc. (“Akero”) (NASDAQ: AKRO) for Potent...
GlobeNewswire
03:00
ENPHASE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Agai...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spr...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Int...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page